Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
80.48 EUR | +0.03% | -1.47% | +33.64% |
Apr. 02 | Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment | MT |
Mar. 12 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |